Viral eradication reduces all-cause mortality in patients with chronic hepatitis C virus infection who had received direct-acting antiviral therapy.
Toshifumi TadaMasayuki KurosakiHidenori ToyodaNobuharu TamakiYutaka YasuiShinichiro NakamuraNami MoriKeiji TsujiHironori OchiTakehiro AkahaneHaruhiko KobashiHideki FujiiHiroyuki MarusawaMasahiko KondoNaohito UrawaHideo YoshidaYasushi UchidaAtsuhiro MoritaChitomi HasebeAkeri MitsudaChikara OgawaRyoichi NaritaYoshihito KubotsuTomomichi MatsushitaMasaya ShigenoEisuke OkamotoKazuhiko OkadaToyotaka KasaiToru IshiiMichiko NonogiSatoshi YasudaYuichi KoshiyamaTakashi KumadaNamiki IzumiPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)
The elimination of HCV via DAA therapy reduced not only liver-related mortality but also non-liver-related mortality in patients with chronic HCV.